Propylisopropyltryptamine

PiPT
Clinical data
Other names	PiPT; N-Propyl-N-isopropyltryptamine
Drug class	Serotonergic psychedelic; Hallucinogen
ATC code	none;
Identifiers
	IUPAC name [2-(1H-indol-3-yl)ethyl]-N-propyl-N-isopropylamine;
CAS Number	1354632-00-0 ;
PubChem CID	57464898;
ChemSpider	21106369 ;
UNII	Q2Y9D5Q4T4;
CompTox Dashboard (EPA)	DTXSID20726699 ;
Chemical and physical data
Formula	C16H24N2
Molar mass	244.382 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)N(CCC)CCc2c[nH]c1ccccc12;
	InChI InChI=1S/C16H24N2/c1-4-10-18(13(2)3)11-9-14-12-17-16-8-6-5-7-15(14)16/h5-8,12-13,17H,4,9-11H2,1-3H3 ; Key:OFXPLOPRCQJJFP-UHFFFAOYSA-N ;
	(what is this?) (verify)

Propylisopropyltryptamine (PiPT), also known as N-propyl-N-isopropyltryptamine, is a psychedelic drug of the tryptamine family. It reportedly produces hallucinogenic effects that resemble those of other related dialkyl tryptamine derivatives, although PiPT is reportedly relatively weak and short-lasting. It has been sold as a designer drug, first being identified in 2021 in British Columbia, Canada.